Accessibility settings

Published on in Vol 28 (2026)

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/98330, first published .
Asian woman wearing a face mask, looking at her smartphone in a dimly lit room.

Multidisciplinary mHealth Rehabilitation for Patients With Abdominal Cancer Who Are Receiving Chemoradiotherapy: Randomized Phase II Trial

Multidisciplinary mHealth Rehabilitation for Patients With Abdominal Cancer Who Are Receiving Chemoradiotherapy: Randomized Phase II Trial

Lei Yang   1 * , PhD, MD ;   Wenbo Wang   1 * , MD, PhD ;   Jing Su   1 * , PhD ;   Yudi Xiong   2 * , MD, PhD ;   Han Wu   1 * , MD, PhD ;   You Wang   1 , MD, PhD ;   Jing Dai   1 , MD, PhD ;   Dedong Cao   3 , MD, PhD ;   Jin Peng   1 , MD, PhD ;   Ling Xia   1 , MD, PhD ;   Huangang Jiang   1 , MD, PhD ;   Hui Xu   1 , MD, PhD ;   Qingyun Wang   1 , MD, PhD ;   Fengxia Chen   1 , MD, PhD ;   Qing Shu   4 , MD, PhD ;   Chizi Hao   4 , MD, PhD ;   Ke Lv   5 , PhD ;   Weihu Shang   6 , PhD ;   Honghong Xu   7 , PhD ;   Ying Zhang   1 , BSN ;   Weidong Chen   2 , MD ;   Ximing Xu   3 , MD, PhD ;   Hanping Shi   8 , MD, PhD ;   Fuxiang Zhou   1 , MD, PhD

1 Department of Radiation and Medical Oncology, Hubei Key Laboratory of Tumor Biological Behaviors, and Hubei Cancer Clinical Study Center, Zhongnan Hospital of Wuhan University, Wuhan, China

2 Department of Radiation Oncology, Hubei Cancer Hospital, Wuhan, Hubei, China

3 Cancer Center, Renmin Hospital of Wuhan University, Wuhan, Hubei, China

4 Department of Rehabilitation Medicine, Zhongnan Hospital of Wuhan University, Wuhan, Hubei, China

5 Wuhan Sports University, Wuhan, Hubei, China

6 Beijing Ainst Medical Technology Co., Ltd, Beijing, China

7 Health Science Center, Peking University, Beijing, Beijing, China

8 Department of Clinical Nutrition, Beijing Shijitan Hospital, Capital Medical University, Beijing, China; State Market Regulation, Key Laboratory of Cancer FSMP for State Market Regulation, Beijing, China

*these authors contributed equally

Corresponding Author:

  • Fuxiang Zhou, MD, PhD
  • Department of Radiation and Medical Oncology
  • Hubei Key Laboratory of Tumor Biological Behaviors, and Hubei Cancer Clinical Study Center, Zhongnan Hospital of Wuhan University
  • Donghu Road 169
  • Wuhan 430071
  • China
  • Phone: 86 02767812592
  • Email: happyzhoufx@sina.com